Table 1
| Â | Â | Mean | S. D. | N | p |
|---|---|---|---|---|---|
Triglycerides (mg/dl) | Previous treatment | 213.8 | 178.3 | 119 | Â |
| Â | Nevirapine | 154.6 | 95.3 | 119 | <0.05 |
TC (mg/dl) | Previous treatment | 203.6 | 48.0 | 119 | Â |
| Â | Nevirapine | 198.1 | 40.5 | 119 | 0.108 |
HDL-C (mg/dl) | Previous treatment | 43.8 | 14.6 | 119 | Â |
| Â | Nevirapine | 49.3 | 16.8 | 119 | <0.05 |
TC/HDL-C | Previous treatment | 5.1 | 1.9 | 119 | Â |
| Â | Nevirapine | 4.3 | 1.3 | 119 | <0.05 |
LDL (mg/dl) | Previous treatment | 120.2 | 38.1 | 107 | Â |
| Â | Nevirapine | 119.2 | 32.7 | 107 | 0.705 |
VLDL (mg/dl) | Previous treatment | 35.1 | 19.4 | 25 | Â |
| Â | Nevirapine | 23.6 | 12.6 | 25 | <0.05 |